CD9
CD9 (CD9 molecule, also known as BA2, P24, TSPAN29, MRP-1 and MIC3) is an integral membrane tetraspanin associated with integrins. It regulates sperm-egg fusion, platelet activation and aggregation, and cell adhesion. Browse Assay Genie's current range of CD9 research reagents below, or read on for the biology behind the target.
CD9 is an integral membrane protein associated with integrins. It regulates several processes, including sperm-egg fusion, platelet activation and aggregation, and cell adhesion. On the surface of oocytes it plays a key role in sperm-egg fusion, possibly by organising multiprotein complexes and the membrane morphology that fusion requires. CD9 also acts as a receptor for PSG17 and regulates paranodal junction formation.
CD9 often acts as a brake on cell fusion. In myoblasts it associates with CD81 and PTGFRN and inhibits myotube fusion during muscle regeneration. In macrophages it associates with CD81 and beta-1 and beta-2 integrins, and prevents their fusion into multinucleated giant cells that ingest complement-opsonised large particles. It also prevents mononuclear progenitors from fusing into osteoclasts, the cells responsible for bone resorption.
The CD9 gene encodes a member of the transmembrane 4 superfamily, the tetraspanin family. Tetraspanins are cell surface glycoproteins with four transmembrane domains that form multimeric complexes with other cell surface proteins. The CD9 protein is found at the cell membrane and in secreted extracellular exosomes. It functions in differentiation, adhesion, cell motility and signal transduction, and its expression plays a critical role in suppressing cancer cell motility and metastasis. HGNC lists CD9 among the CD molecules, tetraspanins and gamete adhesion and fusion factors, and its previous name is CD9 antigen (p24).
CD9 on the oocyte surface plays a key role in sperm-egg fusion, making it a central protein for studying gamete membrane interactions.
CD9 expression helps suppress cancer cell motility and metastasis, and it is also implicated in cell adhesion and tumour spread.
CD9 is involved in platelet activation and aggregation and is associated with integrins that govern cell adhesion.
CD9 restrains myotube, macrophage and osteoclast fusion, relevant to muscle regeneration, giant cell formation and bone resorption.
CD9 is a tetraspanin associated with integrins. It regulates sperm-egg fusion, platelet activation and aggregation, and cell adhesion and motility. It also inhibits fusion of myoblasts, macrophages and osteoclast progenitors, and its expression suppresses cancer cell motility and metastasis.
CD9 is also known as BA2, P24, TSPAN29, MRP-1 and MIC3. Its former HGNC name was CD9 antigen (p24). The TSPAN29 alias reflects its membership of the tetraspanin family, also called the transmembrane 4 superfamily (TM4SF).
Mouse and rat both have a Cd9 ortholog. In disease research, CD9 is linked to tumour metastasis, since its expression suppresses cancer cell motility. Check the datasheet of any product for its validated reactivity.
Other CD molecules, adhesion proteins and tetraspanin-associated targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P21926; product specifications from Assay Genie datasheets.